BRPI0807125A2 - Processo para a preparação de compostos de uréia substituídos por piperidinil - Google Patents

Processo para a preparação de compostos de uréia substituídos por piperidinil

Info

Publication number
BRPI0807125A2
BRPI0807125A2 BRPI0807125-0A2A BRPI0807125A BRPI0807125A2 BR PI0807125 A2 BRPI0807125 A2 BR PI0807125A2 BR PI0807125 A BRPI0807125 A BR PI0807125A BR PI0807125 A2 BRPI0807125 A2 BR PI0807125A2
Authority
BR
Brazil
Prior art keywords
piperidinil
preparation
urea compounds
compounds replaced
replaced
Prior art date
Application number
BRPI0807125-0A2A
Other languages
English (en)
Inventor
Richard D Gless Jr
Original Assignee
Arete Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arete Therapeutics Inc filed Critical Arete Therapeutics Inc
Publication of BRPI0807125A2 publication Critical patent/BRPI0807125A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BRPI0807125-0A2A 2007-01-29 2008-01-28 Processo para a preparação de compostos de uréia substituídos por piperidinil BRPI0807125A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88711407P 2007-01-29 2007-01-29
US97217707P 2007-09-13 2007-09-13
PCT/US2008/052196 WO2008094862A1 (en) 2007-01-29 2008-01-28 Processes for the preparation of piperidinyl-substituted urea compounds

Publications (1)

Publication Number Publication Date
BRPI0807125A2 true BRPI0807125A2 (pt) 2014-04-08

Family

ID=39493517

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807125-0A2A BRPI0807125A2 (pt) 2007-01-29 2008-01-28 Processo para a preparação de compostos de uréia substituídos por piperidinil

Country Status (15)

Country Link
US (1) US20080207908A1 (pt)
EP (1) EP2125729A1 (pt)
JP (1) JP2010516785A (pt)
KR (1) KR20090107045A (pt)
CN (1) CN101663273A (pt)
AR (1) AR065079A1 (pt)
AU (1) AU2008210723A1 (pt)
BR (1) BRPI0807125A2 (pt)
CA (1) CA2675448A1 (pt)
EA (1) EA200901063A1 (pt)
EC (1) ECSP099599A (pt)
IL (1) IL199654A0 (pt)
MX (1) MX2009008093A (pt)
TW (1) TW200838851A (pt)
WO (1) WO2008094862A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090197916A1 (en) * 2007-01-29 2009-08-06 Arete Therapeutics, Inc Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
US7081454B2 (en) * 2001-03-28 2006-07-25 Bristol-Myers Squibb Co. Tyrosine kinase inhibitors
JP4648317B2 (ja) * 2003-08-01 2011-03-09 中外製薬株式会社 マロニル−CoAデカルボキシラーゼ阻害剤として有用なピペリジン化合物
TW200808723A (en) * 2006-03-13 2008-02-16 Univ California Conformationally restricted urea inhibitors of soluble epoxide hydrolase

Also Published As

Publication number Publication date
AU2008210723A1 (en) 2008-08-07
CA2675448A1 (en) 2008-08-07
TW200838851A (en) 2008-10-01
AR065079A1 (es) 2009-05-13
JP2010516785A (ja) 2010-05-20
CN101663273A (zh) 2010-03-03
KR20090107045A (ko) 2009-10-12
EA200901063A1 (ru) 2009-12-30
EP2125729A1 (en) 2009-12-02
IL199654A0 (en) 2010-04-15
US20080207908A1 (en) 2008-08-28
WO2008094862A1 (en) 2008-08-07
ECSP099599A (es) 2009-09-29
MX2009008093A (es) 2009-08-12

Similar Documents

Publication Publication Date Title
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0816258A2 (pt) processo para a preparação de compostos úteis como inibidores de sglt
BRPI0916609A2 (pt) Processo para a preparação de um macrociclo
BRPI0920356A2 (pt) Processo para a preparação de compostos úteis como inibidores de sglt
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0815784A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI0810067A2 (pt) Processo para a preparação de capecitabina
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BR112012014490A2 (pt) processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses
BRPI0816911A2 (pt) Processo para preparação de 4-aminobut-2-enolidas
BRPI0809652A2 (pt) Processo melhorado para a síntese de solifenacina
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
BRPI1013830A2 (pt) Processo para a iodação de compostos aromáticos
BRPI0815971A2 (pt) Processo para a preparação de 1,2-propanodiol
BRPI0811315A2 (pt) Processo para a preparação de um composto
BRPI0914556A2 (pt) Processo para a preparação de compostos de piperazina substituídos por cicloalquila
BRPI1008117A2 (pt) Processo para a sintese de cleistantina
BRPI0821837A2 (pt) Processo para a preparação de 6-substituídas-1-(2h)-isoquinolinonas
BRPI0914792A2 (pt) processo para a preparação de polióis
BR112012002130A2 (pt) processo para a preparação de composto,e, composto intermediário
BRPI1010571A2 (pt) processo para a preparação de um composto útil como um inibidor de tafla.
BRPI0920705A8 (pt) processo para a produção de compostos alquilaromáticos
BRPI0913644A2 (pt) processo para a prepração de derivados de pirimidina substituída.
BRPI0821386A2 (pt) Processo para a preparação de r-lansoprazol amorfo estável

Legal Events

Date Code Title Description
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 3A, 4A, 5A E 6A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A, 6A, 7A, 8A, 9A, 10A, 11A E 12A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.